Download PDF
Dtsch Med Wochenschr 2021; 146(01): 48-57
DOI: 10.1055/a-1212-9393
CME-Fortbildung

Der alte Patient mit akutem Koronarsyndrom – Konservative oder interventionelle Therapie?

The elderly patient with acute coronary syndrome
Luise Gaede
,
Helge Möllmann
› Further Information
Also available at
    Permissions and Reprints

Der alte Patient mit einem akuten Koronarsyndrom (ACS) wird häufig aufgrund des Alters, von Vorerkrankungen und auch erhöhtem Blutungsrisiko nicht evidenzbasiert therapiert. Dies gilt sowohl für die medikamentöse als auch die interventionelle Therapie. Valide Daten zeigen jedoch deutlich, dass gerade auch alte Patienten von einer leitlinienkonformen Therapie – vor allem auch der interventionellen Therapie und der Revaskularisation – profitieren.

Abstract

The elderly patient with acute coronary syndrome (ACS) is often not treated on an evidence based basis due to age, previous illnesses and also an increased risk of bleeding. This applies to both drug and interventional therapy. However, valid data clearly show that elderly patients in particular benefit from guideline-adherent therapy, especially interventional revascularisation.

Schlüsselwörter

akutes Koronarsyndrom - konservative Therapie - interventionelle Therapie

Key words

acute coronary syndrome - conservative therapy - interventional therapy


Publication History

Article published online:
04 January 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Dai X, Busby-Whitehead J, Alexander KP. Acute coronary syndrome in the older adults. J Geriatr Cardiol 2016; 13: 101-108
    PubMedGoogle Scholar
  • 2 Brieger D, Eagle K, Goodman S. et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: Insights from the global registry of acute coronary events. Chest 2004; 126: 461-469
    CrossrefPubMedGoogle Scholar
  • 3 Bayer A, Chadha J, Farag R. et al. Changing Presentation of Myocardial Infarction with increasing old age. JAGS 1986; 34: 263-266
    CrossrefPubMedGoogle Scholar
  • 4 Freisinger E, Fuerstenberg T, Malyar NM. et al. German nationwide data on current trends and management of acute myocardial infarction: Discrepancies between trials and real-life. Eur Heart J 2014; 35: 979-988
    CrossrefPubMedGoogle Scholar
  • 5 Rosengren A, Wallentin L, Simoons M. et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 2006; 27: 789-795
    CrossrefPubMedGoogle Scholar
  • 6 Ibanez B, James S, Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST -segment elevation The Task Force for the management of acute myocardial infarction. Eur Heart J 2018; 39: 119-177
    CrossrefPubMedGoogle Scholar
  • 7 Moscucci M, Fox KAA, Cannon CP. et al. Predictors of major bleeding in acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-1823
    CrossrefPubMedGoogle Scholar
  • 8 Gallagher S, Knight C. Contrast-induced nephropathy in primary percutaneous coronary intervention. Heart 2011; 97: 1723-1725
    CrossrefPubMedGoogle Scholar
  • 9 Skolnick AH, Alexander KP, Chen AY. et al. Characteristics, Management, and Outcomes of 5,557 Patients Age ≥ 90 Years With Acute Coronary Syndromes. Results From the CRUSADE Initiative. J Am Coll Cardiol 2007; 49: 1790-1797
    CrossrefPubMedGoogle Scholar
  • 10 Devlin G, Gore JM, Elliott J. et al. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J 2008; 29: 1275-1282
    CrossrefPubMedGoogle Scholar
  • 11 Bauer T, Koeth O, Jünger C. et al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J 2007; 28: 2873-2878
    CrossrefPubMedGoogle Scholar
  • 12 De Boer MJ, Ottervanger JP, Van’T Hof AWJ. et al. Reperfusion therapy in elderly patients with acute myocardial infarction: A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002; 39: 1723-1728
    CrossrefPubMedGoogle Scholar
  • 13 Bueno H, Betriu A, Heras M. et al. Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio en Ancianos) randomized trial and pooled analysis with previous studies. Eur Heart J 2011; 32: 51-60
    CrossrefPubMedGoogle Scholar
  • 14 Alexander KP, Chen AY, Roe MT. et al. Investigators C. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. [Erratum appears in JAMA 2006 Feb 8; 295(6): 628]. Jama 2005; 294: 3108-3116
    CrossrefPubMedGoogle Scholar
  • 15 Neumann FJ, Sousa-Uva M, Ahlsson A. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87-165
    CrossrefPubMedGoogle Scholar
  • 16 Valgimigli M, Bueno H, Byrne RA. et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J 2018; 39: 213-260
    CrossrefPubMedGoogle Scholar
  • 17 Mehran R, Baber U, Sharmka S. et al. Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med 2019; 38: 1-10
    PubMedGoogle Scholar
  • 18 Collet JP, Thiele H, Barbato E. et al 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST elevation. Eur Heart J 2020; epub ahead of print
    Google Scholar
  • 19 Mockel M, Searle J, Muller R. et al. Chief complaints in medical emergencies: do they relate to Emergency underlying disease and outcome? The Charite Medicine Study (CHARITEM). J Emerg Med 2013; 20: 103-108
    PubMedGoogle Scholar
  • 20 Bach RG, Cannon CP, Weintraub WS. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. ACC Curr J Rev 2004; 13: 53-54
    CrossrefPubMedGoogle Scholar
  • 21 Roffi M, Patrono C, Collet JP. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2016; 37: 1101-1106
    CrossrefPubMedGoogle Scholar
  • 22 Alexander KP, Newby LK, Cannon CP. et al. Acute coronary care in the elderly, part I. Non-ST-segment-elevation acute coronary syndromes: A scientific statement for healthcare professionals from the American heart association council on clinical cardiology. Circulation 2007; 115: 2549-2569
    CrossrefPubMedGoogle Scholar
  • 23 Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. Eur Heart J 2014; 35: 1726-1731
    CrossrefPubMedGoogle Scholar
  • 24 Kirchhof P, Benussi S, Kotecha D. et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-2962
    CrossrefPubMedGoogle Scholar
  • 25 Dewilde WJM, Oirbans T, Verheugt FWA. WOEST study investigators. et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet (London, England) 2013; 381: 1107-1115
    CrossrefPubMedGoogle Scholar
  • 26 Gibson CM, Mehran R, Bode C. et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med 2016; 375: 2423-2434
    CrossrefPubMedGoogle Scholar
  • 27 Cannon CP, Bhatt DL, Oldgren J. et al. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. N Engl J Med 2017; 377: 1513-1524
    CrossrefPubMedGoogle Scholar
  • 28 Vranckx P, Valgimigli M, Eckardt L. et al. Articles Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet 2019; 6736: 1-9
    Google Scholar
  • 29 Lopes R, Heizer G, Aronson R. et al. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med 2019; 380: 1509-1524
    CrossrefPubMedGoogle Scholar
  • 30 Knuuti J, Wijns W, Chairperson I. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic. Eur Heart J 2020; 41: 407-477
    CrossrefPubMedGoogle Scholar
  • 31 Yu J, Mehran R, Grinfeld L. et al. Sex-Based Differences in Bleeding and Long Term Adverse Events After Percutaneous Coronary Intervention for Acute Myocardial Infarction : Three Year Results From the HORIZONS-AMI Trial. Catheter Cardiovasc Interv 2015; 85 (03) 359-368
    CrossrefPubMedGoogle Scholar
  • 32 Yasuda S, Kaikita K, Akao M. et al. Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. N Engl J Med 2019; 381: 1103-1113
    CrossrefPubMedGoogle Scholar
  • 33 Reiter M, Twerenbold R, Reichlin T. et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011; 32: 1379-1389
    CrossrefPubMedGoogle Scholar
  • 34 Liebetrau C, Gaede L, Wolter JS. et al. Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction. Biomarkers 2017; 22: 304-310
    CrossrefPubMedGoogle Scholar
  • 35 Liebetrau C, Nef HM, Dörr O. et al. Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction. Heart 2014; 100: 652-657
    CrossrefPubMedGoogle Scholar